NYSE: ACH
Accendra Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACH

Based on 5 analysts offering 12 month price targets for Accendra Health Inc

Min Forecast
$4.00+109.42%
Avg Forecast
$5.75+201.05%
Max Forecast
$7.00+266.49%

Should I buy or sell ACH stock?

Based on 5 analysts offering ratings for Accendra Health Inc.

Hold
Strong Buy
1 analysts 20%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
1 analysts 20%
Strong Sell
1 analysts 20%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their ACH stock forecasts and price targets.

ACH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-03
lockedlocked$00.00+00.00%2025-08-27
lockedlocked$00.00+00.00%2025-08-12
lockedlocked$00.00+00.00%2025-08-12
lockedlocked$00.00+00.00%2025-08-12

1 of 1

Forecast return on equity

Is ACH forecast to generate an efficient return?

Company
-25.83%
Industry
-117.1%
Market
208.87%
ACH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACH forecast to generate an efficient return on assets?

Company
2.75%
Industry
7.11%
ACH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACH earnings per share forecast

What is ACH's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.98
Avg 2 year Forecast
$1.17
Avg 3 year Forecast
$1.28

ACH revenue forecast

What is ACH's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$2.6B-60.79%
Avg 2 year Forecast
$2.8B-58.58%
Avg 3 year Forecast
$3.1B-54.2%
ACH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACH revenue growth forecast

How is ACH forecast to perform vs Medical Distribution companies and vs the US market?

Company
-23.39%
Industry
7.56%
Market
23.09%
ACH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACH vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
ACH$1.91$5.75+201.05%Hold
EDAP$3.77N/AN/A
SNYR$1.85$7.00+278.38%Strong Buy
COSM$0.54N/AN/A
AHG$1.35N/AN/A

Accendra Health Stock Forecast FAQ

Is Accendra Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: ACH) stock is to Hold ACH stock.

Out of 5 analysts, 1 (20%) are recommending ACH as a Strong Buy, 1 (20%) are recommending ACH as a Buy, 1 (20%) are recommending ACH as a Hold, 1 (20%) are recommending ACH as a Sell, and 1 (20%) are recommending ACH as a Strong Sell.

If you're new to stock investing, here's how to buy Accendra Health stock.

What is ACH's earnings growth forecast for 2026-2028?

(NYSE: ACH) Accendra Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 24.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.53%.

Accendra Health's earnings in 2026 is -$1,340,432,000.On average, 7 Wall Street analysts forecast ACH's earnings for 2026 to be $75,838,335, with the lowest ACH earnings forecast at $62,155,723, and the highest ACH earnings forecast at $92,583,873. On average, 6 Wall Street analysts forecast ACH's earnings for 2027 to be $90,209,333, with the lowest ACH earnings forecast at $78,831,649, and the highest ACH earnings forecast at $108,014,519.

In 2028, ACH is forecast to generate $99,212,476 in earnings, with the lowest earnings forecast at $91,717,591 and the highest earnings forecast at $108,014,519.

What is ACH's revenue growth forecast for 2026-2028?

(NYSE: ACH) Accendra Health's forecast annual revenue growth rate of -23.39% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.09%.

Accendra Health's revenue in 2026 is $6,707,302,000.On average, 7 Wall Street analysts forecast ACH's revenue for 2026 to be $203,421,542,220, with the lowest ACH revenue forecast at $192,128,939,496, and the highest ACH revenue forecast at $219,586,980,366. On average, 6 Wall Street analysts forecast ACH's revenue for 2027 to be $214,868,838,132, with the lowest ACH revenue forecast at $194,526,683,910, and the highest ACH revenue forecast at $230,879,583,090.

In 2028, ACH is forecast to generate $237,608,736,768 in revenue, with the lowest revenue forecast at $230,570,196,714 and the highest revenue forecast at $247,045,021,236.

What is ACH's forecast return on assets (ROA) for 2026-2029?

(NYSE: ACH) forecast ROA is 2.75%, which is lower than the forecast US Medical Distribution industry average of 7.11%.

What is ACH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ACH price target, the average ACH price target is $5.75, with the highest ACH stock price forecast at $7.00 and the lowest ACH stock price forecast at $4.00.

On average, Wall Street analysts predict that Accendra Health's share price could reach $5.75 by Nov 3, 2026. The average Accendra Health stock price prediction forecasts a potential upside of 201.05% from the current ACH share price of $1.91.

What is ACH's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: ACH) Accendra Health's current Earnings Per Share (EPS) is -$17.42. On average, analysts forecast that ACH's EPS will be $0.98 for 2026, with the lowest EPS forecast at $0.80, and the highest EPS forecast at $1.20. On average, analysts forecast that ACH's EPS will be $1.17 for 2027, with the lowest EPS forecast at $1.02, and the highest EPS forecast at $1.40. In 2028, ACH's EPS is forecast to hit $1.28 (min: $1.19, max: $1.40).

What is ACH's forecast return on equity (ROE) for 2026-2029?

(NYSE: ACH) forecast ROE is -25.83%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.